The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The In Vitro Cancer Diagnostics Market Through 2030?
The in vitro cancer diagnostics market has demonstrated considerable growth in recent years. It is projected to expand from $11.49 billion in 2025 to $12.36 billion in 2026, registering a compound annual growth rate (CAGR) of 7.6%. This market’s past expansion can be ascribed to several contributing factors, including an increase in cancer prevalence, the widespread adoption of molecular diagnostics, the ongoing development of immunoassay kits, the proliferation of diagnostic laboratories, and advancements in reagent technologies.
The in vitro cancer diagnostics market is anticipated to experience substantial expansion over the coming years. Its size is projected to reach $16.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This projected growth during the forecast period can be attributed to several factors, including AI-enabled predictive analytics, the broadening of personalized oncology, advancements in high-throughput sequencing platforms, the rise of point-of-care diagnostics, and the increased adoption of cloud-based diagnostic software. Key trends for the same period encompass biomarker-based detection, genetic profiling tools, the evolution of multiplex assay development, integration with laboratory information systems (LIMS), and the availability of rapid diagnostic kits.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29090&type=smp
What Influential Factors Are Boosting The In Vitro Cancer Diagnostics Market Demand?
The increased utilization of liquid biopsy technologies is projected to spur the expansion of the in vitro cancer diagnostics market. These technologies are characterized as minimally invasive diagnostic approaches that identify and analyze biomarkers, such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), or exosomes, found in bodily fluids like blood, urine, or saliva. This analysis helps monitor disease presence, progression, or response to treatment, particularly in cancer. The expansion of liquid biopsy technologies is propelled by breakthroughs in isolating and examining circulating tumor DNA and circulating tumor cells from blood and other body fluids. Consequently, in vitro cancer diagnostic solutions are experiencing heightened demand as the swift proliferation of liquid biopsy technologies prompts companies to embrace non-invasive, real-time molecular profiling tools for cancer detection and treatment guidance. For example, in May 2025, NHS England, a UK-based public healthcare system, commenced the initial rollout of a new liquid biopsy blood test in the UK. This initiative is anticipated to benefit up to 15,000 patients with suspected lung cancer and 5,000 women with advanced breast cancer annually, with testing scaling rapidly from approximately 2,200 patients during the early 2025 rollout to an estimated 20,000 patients per year by 2028. Therefore, the growing acceptance of liquid biopsy technologies is stimulating demand for the in vitro cancer diagnostics market.
How Are Different Segment Groups Identified Within The In Vitro Cancer Diagnostics Market?
The in vitro cancer diagnostics market covered in this report is segmented –
1) By Product Type: Kits, Instruments, Reagents, Software, Consumables
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry, Other Technologies
3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Kits: Immunoassay Kits, Polymerase Chain Reaction (PCR) Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Flow Cytometry Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Instruments, Sequencers, Flow Cytometers, Imaging Systems
3) By Reagents: Enzymes, Buffers, Probes, Stains
4) By Software: Data Analysis Software, Imaging Software, Laboratory Information Management System (LIMS) Software, Diagnostic Reporting Software
5) By Consumables: Microplates, Pipette Tips, Tubes, Slides
Which Trends Are Contributing To Changes In The In Vitro Cancer Diagnostics Market?
Leading firms in the in vitro cancer diagnostics market are prioritizing the development of AI-powered cancer diagnostics to elevate patient care and advance personalized healthcare. This type of AI-driven diagnostic involves utilizing artificial intelligence to analyze medical and molecular data from patient samples, imaging, or genetic tests, thereby enabling more accurate detection, diagnosis, and prediction of cancer. For instance, in September 2024, Roche, a Switzerland-based pharmaceutical company, unveiled the Digital Pathology Open Environment. This collaborative platform securely integrates advanced AI-based image analysis tools from Roche as well as multiple third-party developers. The platform empowers pathologists to access innovative algorithms within Roche’s Navify Digital Pathology enterprise software, enhancing diagnostic precision and improving workflow efficiency. By fostering collaboration and data sharing, the platform accelerates innovation in cancer diagnostics and research, supports precision medicine, and facilitates targeted treatments, ultimately broadening access to cutting-edge digital pathology tools worldwide.
Who Are The Firms Contributing To The In Vitro Cancer Diagnostics Market Ecosystem?
Major companies operating in the in vitro cancer diagnostics market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc, Hologic Inc, Qiagen N.V, Bio-Rad Laboratories Inc, Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, LabCorp Holding Corp., Guardant Health, Quest Diagnostics, Exact Sciences, Myriad Genetics Inc, Natera Inc., NeoGenomics Laboratories, NanoString Technologies Inc, Caris Life Sciences, Transasia Bio-Medicals Ltd, Autobio Diagnostics Co Ltd, QuidelOrtho Corporation, Cancer Diagnostics Inc, Predicine Inc, Strata Oncology, Biocept Inc, Lucence Diagnostics
Access The Complete In Vitro Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/in-vitro-cancer-diagnostics-global-market-report
Which Region Is The Primary Market For The In Vitro Cancer Diagnostics Market?
North America was the largest region in the in vitro cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a In Vitro Cancer Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/in-vitro-cancer-diagnostics-global-market-report
Browse Through More Reports Similar to the Global In Vitro Cancer Diagnostics Market 2026, By The Business Research Company
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Bioinformatics In In Vitro Diagnostics Ivd Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model